Joseph E Gilliam sold $499K of Glaukos (GKOS)

Executed Dec 20 2024, disclosed Dec 23 2024, 3 days later.

Value, as filed

$499K

3,328 sh across 2 lots

Executed

Dec 20 2024

the trade date, as filed

Disclosed

Dec 23 2024

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Joseph E Gilliam PRESIDENT & COO profile →

Joseph E Gilliam (PRESIDENT & COO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Glaukos Corporation (GKOS). The largest single filing was $10.8M of GKOS (60,000 sh across 2 lots, as filed), executed Aug 11.

The name

GKOS

Glaukos Corporation GKOS · Healthcare · 31 filings in 24 months ticker →

Healthcare · Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph E Gilliam in GKOS

GKOSSALE Glaukos Corporation $10.8M
60,000 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 7:57 PM ET GKOSSALE Glaukos Corporation $2.8M
19,573 sh × $143.54
Exec May 1
Filed May 4 · 5:30 PM ET GKOSSALE Glaukos Corporation $1.3M
10,498 sh across 4 lots
Exec Jan 22
Filed Jan 26 · 5:30 PM ET GKOSSALE Glaukos Corporation $561K
4,502 sh × $124.65
Exec Jan 21
Filed Jan 23 · 5:30 PM ET GKOSSALE Glaukos Corporation $1.7M
19,340 sh × $90.00
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET GKOSSALE Glaukos Corporation $316K
2,275 sh × $138.97
Exec Oct 30 2024
Filed Nov 1 2024 · 5:30 PM ET